---
figid: PMC8721938__44_2021_2841_Sch1_HTML
figtitle: Review on molnupiravir as a promising oral drug for the treatment of COVID-19
organisms:
- Severe acute respiratory syndrome coronavirus 2
- Coronaviridae
- Severe acute respiratory syndrome-related coronavirus
- Ebola virus sp.
- Homo sapiens
- Mus musculus
- Mustela putorius furo
organisms_ner:
- Homo sapiens
pmcid: PMC8721938
filename: 44_2021_2841_Sch1_HTML.jpg
figlink: /pmc/articles/PMC8721938/figure/Sch1/
number: S1
caption: Synthetic pathway revealed from molnupiravir by Emory University in 2019.
papertitle: Review on molnupiravir as a promising oral drug for the treatment of COVID-19.
reftext: Elham Zarenezhad, et al. Med Chem Res. 2022;31(2):232-243.
year: '2022'
doi: 10.1007/s00044-021-02841-3
journal_title: Medicinal Chemistry Research
journal_nlm_ta: Med Chem Res
publisher_name: Springer US
keywords: COVID-19 | Molnupiravir | Mechanism of action | Synthetic pathway | Molecular
  docking
automl_pathway: 0.9286737
figid_alias: PMC8721938__S1
figtype: Scheme
redirect_from: /figures/PMC8721938__S1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8721938__44_2021_2841_Sch1_HTML.html
  '@type': Dataset
  description: Synthetic pathway revealed from molnupiravir by Emory University in
    2019.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TSPAN2
  - NDC1
  - RAB8A
  - MAP2K1
  - ME1
  - PCDHB16
---
